MedTrace Logo

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

NCT00828555 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3988

Last updated 2012-10-16

No results posted yet for this study

Summary

PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.

SPECIFIC AIMS

1. Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel \& office staff on their:

* Attitudes towards vaccination of women against preventable diseases
* Perceived barriers to implementing a program to vaccinate women in their offices
* Ideas on how to overcome barriers to successful program implementation
* Current vaccination practices and office-specific administrative processes
2. Design \& implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, \& pertussis
3. Determine the effectiveness of the vaccination program based on

* Pre- and post-program vaccination rates
* Program satisfaction amongst Ob/Gyn providers and office staff
* Willingness to continue and possibly extend the program to additional vaccines
4. Quantify the level of support and resources needed to develop and implement the vaccination program

Conditions

  • Influenza Vaccine
  • Papillomavirus Infection
  • Pertussis

Interventions

OTHER

Vaccination Program

Design \& implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, \& pertussis

Sponsors & Collaborators

Principal Investigators

  • Geeta Swamy, MD · Duke University

Eligibility

Min Age
12 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-04-30
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00828555 on ClinicalTrials.gov